Rating: Category:

AASraw is with synthesis and production ability from gram to mass order of Apatinib (CAS 811803-05-1), under CGMP regulation and trackable quality control system.

Apatinib, a novel small molecule tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-2, was approved for metastatic gastric adenocarcinoma in China in Oct 2014. This is the first report on its use for advanced colorectal cancer as a kind of third-line therapy to date.   

AASRAW powder PDF Icon

Product Description


Apatinib video




I.Apatinib basic Characters:


Name: Apatinib
CAS: 811803-05-1
Molecular Formula: C24H23N5O
Molecular Weight: 397.47232
Melt Point: 111-114°C
Storage Temp: -20°C
Color: Pale Yellow to Yellow Solid



II. Apatinib (811803-05-1)usage in steroids cycle


1. Names:

Apatinib (CAS 811803-05-1), also known as YN968D1, Mesylate.


2. Apatinib Usage:

Cancer patients were administered varied doses of Apatinib daily for 28 days. Apatinib was well tolerated at doses below 750 mg/day, 3 of 3 dose limiting toxicities were reported at 1000 mg/day and the maximum tolerated dose is determined to be850 mg/day.


3.Warning on Apatinib

You must know the side effects when you take Apatinib. The common side effectsof apatinib were hypertension and hand-foot syndrome; however, the toxicity of apatinib was controllable and tolerable.


4.Further instructions:

Rivoceranib (Apatinib, YN968D1) is an orally bioavailable experimental drug candidate being developed outside of China by LSK BioPharma, for the treatment of solid tumors including advanced or metastatic gastric cancer, colorectal cancer, and hepatocellular carcinoma. YN968D1 was first synthesized and patented by Advenchen Laboratories in Southern California. Apatinib is currently marketed in China for advanced gastric cancer by the Chinese-territory license-holder, Jiangsu Hengrui MedicineCo., Ltd under the brand name Aitan®. LSK BioPharma holds the global rights (excluding China) and has partnered for the development and marketing of rivoceranibin South Korea.

Rivoceranib is a selective potent inhibitor of vascular endothelial growth factor receptor-2 (known as VEGFR2) which mediates the primary pathway for tumor-mediatedangiogenesis. It has been clinically tested in over 1,000 patients worldwide and hasdemonstrated efficacy in numerous cancers including gastric cancer, colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, esophageal cancer, thyroidcancer, mesothelioma, and neuroendocrine tumors. It has also shown potential tosignificantly improve outcomes in combination with chemotherapeutics and immunotherapy, as well as for maintenance therapy.


III. Apatinib (811803-05-1) HCML

We are Aprepitant powder supplie,Aprepitant powder for sale,Raw Aprepitant powder (170729-80-3) hplc≥98% | AASraw R&D Reagents



IV. How to buy Apatinib from AASraw?


1.To contact us by our email inquiry system,or online skypecustomer service representative(CSR).
2.To provide us your inquired quantity and address.
3.Our CSR will provide you the quotation, payment term, tracking number, delivery ways and estimated arrival date(ETA).
4.Payment done and the goods will be sent out in 12 hours(For order within 10kg).
5.Goods received and give comments.



Guess your favorite product blog:


How to use Clenbuterol for weight loss What is nandrolone powder used for/nandrolone benefits?



More detail about relevant products,welcome to click here.



There are no reviews yet.

Be the first to review “Apatinib”